Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Assessment of specific molecular pathways that contribute totrifarotene efficacy in acne by comparing the transcriptome of spontaneously resolved papules with that of papules treated with the retinoid

Next Previous
X
Search
Trial Profile

Assessment of specific molecular pathways that contribute totrifarotene efficacy in acne by comparing the transcriptome of spontaneously resolved papules with that of papules treated with the retinoid

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 09 May 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Trifarotene (Primary)
  • Indications Acne
  • Focus Pharmacodynamics; Pharmacogenomic

    • Most Recent Events

    • 21 Mar 2023 Results investigating which molecular acne pathways trifarotene acts on by comparing the transcriptome of naturally resolving papules vs those trifarotene treated , presented at the American Academy of Dermatology annual Meeting 2023
    • 14 Jun 2021 New trial record
    • 25 Apr 2021 Results presented at the American Academy of Dermatology Virtual Meeting Experience 2021

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top